Koichi Kusuhara Selected Research

Subacute Sclerosing Panencephalitis (SSPE)

1/2021	Favorable outcomes of interferon-α and ribavirin treatment for a male with subacute sclerosing panencephalitis.
6/2010	[Genetic susceptibility to infectious diseases: immunogenetical approaches to mycobacterial infections and subacute sclerosing panencephalitis].
11/2008	Association of toll-like receptor 3 gene polymorphism with subacute sclerosing panencephalitis.
8/2007	[Host genetic factors for the development of SSPE].
1/2007	Serum levels of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 in subacute sclerosing panencephalitis.
7/2005	Gene expression profiles in peripheral blood mononuclear cells from patients with subacute sclerosing panencephalitis using oligonucleotide microarrays.
5/2002	Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichi Kusuhara Research Topics

Disease

7	Subacute Sclerosing Panencephalitis (SSPE) 01/2021 - 05/2002
5	Respiratory Tract Infections (Respiratory Tract Infection) 03/2022 - 10/2014
5	Pneumonia (Pneumonitis) 12/2021 - 10/2007
4	Neoplasms (Cancer) 06/2022 - 11/2005
4	Hemophilia A (Haemophilia) 06/2022 - 01/2018
4	Asthma (Bronchial Asthma) 03/2022 - 10/2018
4	Infections 12/2021 - 04/2008
4	Hemorrhage 01/2021 - 06/2010
3	Birth Weight (Birth Weights) 01/2019 - 01/2014
3	Sepsis (Septicemia) 11/2018 - 06/2009
3	Obesity 09/2016 - 08/2010
3	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2015 - 04/2003
3	Human Influenza (Influenza) 06/2009 - 11/2005
2	Respiratory Sounds (Crackle) 03/2022 - 01/2022
2	Intellectual Disability (Idiocy) 03/2022 - 01/2018
2	Hypersensitivity (Allergy) 01/2021 - 03/2020
2	Placenta Previa 01/2020 - 06/2019
2	Premature Birth (Birth, Premature) 01/2020 - 10/2018
2	Meningitis 08/2015 - 06/2009
2	Pediatric Obesity 01/2014 - 08/2010
2	Seizures (Absence Seizure) 01/2013 - 01/2011
2	Inflammation (Inflammations) 08/2012 - 05/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2012 - 04/2008
2	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2012 - 10/2007
2	Genetic Predisposition to Disease (Genetic Predisposition) 06/2010 - 05/2002
2	Measles 08/2007 - 07/2005
1	Airway Obstruction (Choking) 06/2022
1	Epistaxis (Nosebleed) 06/2022
1	Weight Gain 01/2022
1	Mumps 12/2021
1	Neurodevelopmental Disorders 11/2021
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2021
1	Glaucoma 01/2021
1	Endocarditis 01/2021
1	Atopic Dermatitis (Atopic Eczema) 03/2020
1	Eczema 03/2020
1	Gastroenteritis 03/2020
1	Anorexia 01/2020
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2020
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Hearing Loss (Hearing Impairment) 12/2019

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 03/2020 - 05/2002
4	InterferonsIBA 01/2021 - 05/2002
4	Biomarkers (Surrogate Marker)IBA 11/2018 - 01/2011
3	VaccinesIBA 12/2021 - 03/2006
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2008
3	ChemokinesIBA 03/2020 - 05/2011
2	CholesterolIBA 01/2022 - 04/2012
2	Rotavirus VaccinesIBA 12/2021 - 03/2020
2	Hemostatics (Antihemorrhagics)IBA 01/2021 - 06/2009
2	16S Ribosomal RNAIBA 11/2020 - 10/2019
2	ManganeseIBA 06/2019 - 10/2018
2	CadmiumIBA 06/2019 - 10/2018
2	SeleniumIBA 06/2019 - 10/2018
2	MercuryIBA 06/2019 - 10/2018
2	Hormones (Hormone)IBA 01/2019 - 04/2017
2	AntibodiesIBA 11/2018 - 07/2010
2	AutoantibodiesIBA 11/2018 - 01/2018
2	Conjugate VaccinesIBA 10/2018 - 05/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 05/2017
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2017 - 01/2014
2	ProcalcitoninIBA 12/2016 - 08/2015
2	SteroidsIBA 08/2012 - 04/2012
2	Matrix Metalloproteinases (MMPs)IBA 05/2011 - 01/2007
2	Metalloproteases (Metalloproteinases)IBA 05/2011 - 01/2007
2	NucleotidesIBA 05/2011 - 06/2010
2	DNA (Deoxyribonucleic Acid)IBA 07/2010 - 08/2003
2	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 06/2010 - 05/2002
2	Interleukin-4 (Interleukin 4)IBA 06/2010 - 05/2002
2	OligonucleotidesIBA 08/2007 - 07/2005
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2007 - 07/2005
2	Messenger RNA (mRNA)IBA 08/2007 - 07/2005
2	Immunoglobulin G (IgG)IBA 03/2006 - 11/2005
1	Factor VIIa (Activated Factor VII)IBA 06/2022
1	emicizumabIBA 06/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022
1	KeroseneIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	ORALIT (ORS)IBA 01/2022
1	Valganciclovir FDA Link 12/2021
1	Volatile Organic CompoundsIBA 11/2021
1	Ribavirin (Virazole)FDA LinkGeneric 01/2021
1	Daptomycin FDA Link 01/2021
1	Ophthalmic Solutions (Eye Drops)IBA 01/2021
1	Factor VIII (Coagulation Factor VIII)IBA 01/2021
1	K-115IBA 01/2021
1	Egg ProteinsIBA 01/2021
1	Chemokine CCL22IBA 03/2020
1	Interleukin-33IBA 03/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Immunoglobulin E (IgE)IBA 01/2020
1	CreatinineIBA 12/2019
1	Gentamicins (Gentamicin)FDA LinkGeneric 12/2019

Therapy/Procedure

12	Therapeutics 03/2022 - 06/2009
4	Drug Therapy (Chemotherapy) 01/2011 - 08/2003
3	Oral Administration 01/2014 - 04/2008
3	Hematopoietic Stem Cell Transplantation 04/2012 - 08/2003
1	Tracheostomy 06/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 06/2022
1	Intraventricular Infusions 01/2021